Related Experiment Video

Updated: Jun 5, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Antroquinonol inhibits NSCLC proliferation by altering PI3K/mTOR proteins and miRNA expression profiles

V Bharath Kumar1, Ta-Chun Yuan, Je-Wen Liou

  • 1Department of Life Science, National Dong Hwa University, Hualien, Taiwan.

Mutation Research
|December 28, 2010
PubMed

Insights

Antroquinonol effectively inhibits non-small cell lung cancer (NSCLC) cell proliferation by inducing apoptosis and disrupting key survival pathways. This compound shows promise as a novel chemotherapeutic agent for lung cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Antroquinonol, derived from Antrodia camphorata, exhibits known antitumor properties.
  • The precise mechanisms of antroquinonol's action on non-small cell lung cancer (NSCLC) cell signaling and survival pathways require further elucidation.

Purpose of the Study:

  • To investigate the antiproliferative effects of antroquinonol on NSCLC cells.
  • To delineate the molecular mechanisms underlying antroquinonol-induced apoptosis and cell cycle arrest in NSCLC.

Main Methods:

  • Treatment of A549 NSCLC cells with varying doses and durations of antroquinonol.
  • Assessment of cell proliferation, apoptosis markers (TUNEL assay, Sub-G1 population, caspase activation, PARP cleavage), mitochondrial membrane potential, and protein expression (cdc2, cyclin B1, Bcl2, PI3K, mTOR).
  • Microarray analysis to evaluate miRNA expression changes.

Main Results:

  • Antroquinonol significantly reduced NSCLC cell proliferation in a dose- and time-dependent manner.
  • Apoptosis was induced, evidenced by increased cell shrinkage, apoptotic vacuoles, pore formation, TUNEL positivity, and Sub-G1 cell accumulation.
  • Antroquinonol decreased cdc2 protein levels, disrupted mitochondrial membrane potential, activated Caspase 3 and PARP, downregulated Bcl2, and reduced PI3K/mTOR signaling.
  • Microarray analysis revealed alterations in miRNA expression profiles.

Conclusions:

  • Antroquinonol exhibits significant antiproliferative effects on NSCLC A549 cells.
  • The anticancer mechanism involves apoptosis induction and modulation of critical cell survival pathways.
  • Antroquinonol represents a potential novel chemotherapeutic agent for lung cancer.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...